Related Experiment Videos
cAMP potentiates beta-amyloid-induced nitric oxide release from microglia
1Department of Pharmacology, Ajou University School of Medicine, Suwon, Kyunggi-do, Korea.
Neuroreport
|March 27, 1999
Summary
Elevated cyclic adenosine monophosphate (cAMP) levels enhance beta-amyloid peptide (Abeta)-induced microglial activation and nitric oxide (NO) release. This suggests cAMP plays a key role in neuroinflammation associated with Abeta.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Beta-amyloid peptide (Abeta) is implicated in neurodegenerative diseases.
- Microglia are key immune cells in the brain that activate in response to Abeta.
- Microglial activation can lead to the release of nitric oxide (NO).
Purpose of the Study:
- To investigate the role of cyclic adenosine monophosphate (cAMP) in Abeta-induced microglial activation.
- To determine how intracellular cAMP levels affect nitric oxide (NO) production by microglia.
Main Methods:
- Primary rat brain microglia cultures were used.
- Cells were treated with different forms of Abeta (Abeta25-35 and Abeta1-42).
- The effects of cAMP-elevating agents (dibutyryl-cAMP, IBMX, forskolin) on NO release and inducible nitric oxide synthase (iNOS) expression were measured.
Main Results:
- Dibutyryl-cAMP and IBMX dose-dependently potentiated Abeta-induced NO release.
- This potentiation was linked to increased expression of inducible nitric oxide synthase (iNOS).
- Forskolin showed a biphasic effect, weakly increasing NO at lower concentrations and decreasing it at higher concentrations.
Conclusions:
- Increased intracellular cAMP levels can potentiate Abeta-induced microglial activation.
- cAMP signaling pathways may represent a therapeutic target for modulating neuroinflammation in Abeta-related conditions.